Detalhe da pesquisa
1.
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.
J Infect Dis
; 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38421006
2.
The impact of pre-transplant respiratory virus detection on post-transplant outcomes in children undergoing hematopoietic cell transplantation.
Clin Infect Dis
; 2024 Apr 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38666501
3.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36126318
4.
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
Crit Care
; 27(1): 323, 2023 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37620828
5.
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
Am J Hematol
; 97(8): E312-E317, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35702878
6.
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Eur J Haematol
; 96(2): 175-80, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25880378
7.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37966980
8.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38533127
9.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36923264
10.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol
; 14: 1125030, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36911708
11.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv
; 7(11): 2645-2655, 2023 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37058479
12.
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Front Oncol
; 12: 992137, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36276116
13.
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.
EBioMedicine
; 74: 103705, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34861491
14.
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.
Blood Adv
; 6(7): 2427-2433, 2022 04 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34749396
15.
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey.
Blood Adv
; 6(13): 3870-3874, 2022 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35500220
16.
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.
Transpl Immunol
; 25(2-3): 153-8, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21712089
17.
Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation.
Transplantation
; 86(5): 686-96, 2008 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18791450
18.
The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Br J Haematol
; 119(4): 1133-6, 2002 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-12472598
19.
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Biol Blood Marrow Transplant
; 10(3): 195-203, 2004 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-14993885